Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubenimex in Adult Patients With Lymphedema of The Lower Limb
NCT02700529Phase 2Completed
- Sponsor
- Eiger BioPharmaceuticals, Inc.
- Start
- Jun 2016
- Primary completion
- Oct 2018
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ubenimex in lymphedema, sponsored by Eiger BioPharmaceuticals, Inc.. Started Jun 2016; status: completed.
02
Drugs
ubenimex
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT02700529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700529.